Showing results (121-130 of 259) with videos related to

Sort By:
Pageof 26
Leukemia & Lymphoma|June 21, 2012
Further stratification of patients with multiple myeloma by International Staging System in combination with ratio of serum free κ to λ light chainsYan Xu, Weiwei Sui, Shuhui Deng, et al.
Frontiers in Immunology|July 24, 2023
Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in ChinaYuting Yan, Rui Lv, Tingyu Wang, et al.
Blood Advances|January 24, 2025
Acquired mutations in patients with relapsed/refractory CLL who progressed in the ALPINE studyJennifer R Brown, Jessica Li, Barbara F Eichhorst, et al.
Blood|March 2, 2019
Carfilzomib or bortezomib with melphalan-prednisone for transplant-ineligible patients with newly diagnosed multiple myelomaThierry Facon, Jae Hoon Lee, Philippe Moreau, et al.
British Journal of Haematology|January 22, 2026
A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321Shuhua Yi, Jiang Cao, Ru Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström MacroglobulinemiaGang An, Daobin Zhou, Shu Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2025
Zanubrutinib plus Ixazomib and Dexamethasone in Newly Diagnosed Symptomatic Waldenström Macroglobulinemia: A Phase II StudyWenjie Xiong, Yuting Yan, Tingyu Wang, et al.
Haematologica|May 29, 2025
Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencingLanting Liu, Hao Sun, Fangshuo Feng, et al.
Cancer Medicine|February 13, 2024
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomesHuimin Liu, Hesong Zou, Dandan Shan, et al.
Haematologica|August 3, 2023
Minor clone of del(17p) provides a reservoir for relapse in multiple myelomaJian Cui, Rui Lv, Tengteng Yu, et al.
Pageof 26